Rs 621 crore bank fraud: 3 pharma firm directors booked

Published On 2018-04-20 04:45 GMT   |   Update On 2018-04-20 04:45 GMT

New Delhi: The CBI has registered a case against Surya Pharmaceuticals, its directors and officials of three companies based in Dubai and Patiala for allegedly cheating a consortium of five banks to the tune of Rs 621 crore, officials said on Tuesday.


A case has been registered on charges of criminal conspiracy, cheating, forgery under the provisions of the Prevention of Corruption Act against Surya Pharmaceutical Ltd, its promoters and directors Rajeev Goel and Alka Goel.









Pramod Aggarwal, director of Dubai-based Kobian Pvt Ltd and proprietor of Nimbus FZE, and Suhail Goel, director of Patiala-based Emsons Organic Ltd have also been booked.







"Searches were conducted today at seven places -- two each in Delhi, Patiala and Chandigarh and one in Panchkula -- at the offices and residences of the accused which led to the recovery of certain documents," the CBI spokesperson said here.


It is alleged that the accused defrauded the Punjab and Sindh Bank and four other banks of the consortium to the tune of about Rs 621 crore by diversion and siphoning off the loan through its sister concerns and not utilizing the credit for the purpose it was sanctioned i.e., manufacturing of pharmaceuticals, the spokesperson said.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News